Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference
Tempus AI (NASDAQ: TEM) has announced its participation in the upcoming Morgan Stanley Technology, Media & Telecom Conference scheduled for March 3-6, 2025, in San Francisco, CA. The company's Founder and CEO, Eric Lefkofsky, will engage in a fireside discussion on March 3, 2025. The event will be accessible to viewers through a live webcast.
Tempus, which specializes in leveraging AI technology for precision medicine and patient care advancement, will use this platform to share insights about their operations and innovations. This participation represents an important opportunity for investors and stakeholders to gain direct insights into the company's strategies and developments.
Tempus AI (NASDAQ: TEM) ha annunciato la sua partecipazione alla prossima Conferenza su Tecnologia, Media e Telecomunicazioni di Morgan Stanley, in programma dal 3 al 6 marzo 2025, a San Francisco, CA. Il fondatore e CEO dell'azienda, Eric Lefkofsky, parteciperà a una discussione informale il 3 marzo 2025. L'evento sarà accessibile agli spettatori tramite una diretta web.
Tempus, che si specializza nell'utilizzo della tecnologia AI per la medicina di precisione e il miglioramento della cura dei pazienti, utilizzerà questa piattaforma per condividere intuizioni sulle proprie operazioni e innovazioni. Questa partecipazione rappresenta un'importante opportunità per investitori e parti interessate di ottenere informazioni dirette sulle strategie e gli sviluppi dell'azienda.
Tempus AI (NASDAQ: TEM) ha anunciado su participación en la próxima Conferencia de Tecnología, Medios y Telecomunicaciones de Morgan Stanley, programada del 3 al 6 de marzo de 2025, en San Francisco, CA. El fundador y CEO de la empresa, Eric Lefkofsky, participará en una discusión informal el 3 de marzo de 2025. El evento será accesible para los espectadores a través de una transmisión en vivo.
Tempus, que se especializa en aprovechar la tecnología de IA para la medicina de precisión y el avance en el cuidado del paciente, utilizará esta plataforma para compartir conocimientos sobre sus operaciones e innovaciones. Esta participación representa una oportunidad importante para que inversores y partes interesadas obtengan información directa sobre las estrategias y desarrollos de la empresa.
템푸스 AI (NASDAQ: TEM)가 2025년 3월 3일부터 6일까지 샌프란시스코, CA에서 열리는 모건 스탠리 기술, 미디어 및 통신 컨퍼런스에 참여한다고 발표했습니다. 회사의 창립자이자 CEO인 에릭 레프코프스키가 2025년 3월 3일에 화상 대화에 참여할 예정입니다. 이 행사는 생중계를 통해 시청자에게 제공됩니다.
정밀 의학 및 환자 치료 발전을 위한 AI 기술 활용을 전문으로 하는 템푸스는 이 플랫폼을 통해 운영 및 혁신에 대한 통찰력을 공유할 것입니다. 이번 참여는 투자자와 이해관계자에게 회사의 전략과 발전에 대한 직접적인 통찰을 얻을 수 있는 중요한 기회를 제공합니다.
Tempus AI (NASDAQ: TEM) a annoncé sa participation à la prochaine Conférence Morgan Stanley sur la technologie, les médias et les télécommunications, qui se tiendra du 3 au 6 mars 2025 à San Francisco, CA. Le fondateur et PDG de l'entreprise, Eric Lefkofsky, participera à une discussion informelle le 3 mars 2025. L'événement sera accessible aux spectateurs via une diffusion en direct.
Tempus, qui se spécialise dans l'utilisation de la technologie AI pour la médecine de précision et l'avancement des soins aux patients, utilisera cette plateforme pour partager des informations sur ses opérations et ses innovations. Cette participation représente une opportunité importante pour les investisseurs et les parties prenantes d'obtenir des informations directes sur les stratégies et les développements de l'entreprise.
Tempus AI (NASDAQ: TEM) hat seine Teilnahme an der bevorstehenden Morgan Stanley Technologie-, Medien- und Telekommunikationskonferenz angekündigt, die vom 3. bis 6. März 2025 in San Francisco, CA, stattfinden wird. Der Gründer und CEO des Unternehmens, Eric Lefkofsky, wird am 3. März 2025 an einer informellen Diskussion teilnehmen. Die Veranstaltung wird für Zuschauer über einen Live-Stream zugänglich sein.
Tempus, das sich auf die Nutzung von KI-Technologie zur Präzisionsmedizin und zur Verbesserung der Patientenversorgung spezialisiert hat, wird diese Plattform nutzen, um Einblicke in seine Abläufe und Innovationen zu teilen. Diese Teilnahme stellt eine wichtige Gelegenheit für Investoren und Interessengruppen dar, direkte Einblicke in die Strategien und Entwicklungen des Unternehmens zu erhalten.
- None.
- None.
Tempus Founder and CEO, Eric Lefkofsky, will participate in a fireside discussion at the conference on Monday, March 3, 2025. A live webcast of the conversation will be available here.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus’ industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding Tempus’ and its employee’s potential future speaking engagements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “going to,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release.
You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus’ business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Tempus’ financial performance; the ability to attract and retain customers and partners; managing Tempus’ growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus’ intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled “Risk Factors” in Tempus’ Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed with the Securities and Exchange Commission (“SEC”) as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218840211/en/
Erin Carron
media@tempus.com
Source: Tempus AI, Inc.
FAQ
When is Tempus (TEM) presenting at the Morgan Stanley Tech Conference 2025?
Where can investors watch Tempus's (TEM) Morgan Stanley conference presentation?
What is the location of the Morgan Stanley conference where TEM will present?
Who will represent Tempus (TEM) at the Morgan Stanley Tech Conference 2025?
What type of technology does Tempus (TEM) specialize in?
